Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents
碩士 === 國立中興大學 === 材料科學與工程學系所 === 100 === Although the initial success of bare metal stents (BMS) has significantly reduced the restenosis rate from 35% for Percutaneous transluminal coronary angioplasty (PTCA) to 25%, the biological mechanism such as smooth muscle cell proliferation and neointimal...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/01856005936605595944 |
id |
ndltd-TW-100NCHU5159016 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-100NCHU51590162016-10-23T04:11:28Z http://ndltd.ncl.edu.tw/handle/01856005936605595944 Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents 被覆含肝素多層複合材於鎳鈦合金應用於心臟血管支架之研究 Po-Yin Cheng 鄭博尹 碩士 國立中興大學 材料科學與工程學系所 100 Although the initial success of bare metal stents (BMS) has significantly reduced the restenosis rate from 35% for Percutaneous transluminal coronary angioplasty (PTCA) to 25%, the biological mechanism such as smooth muscle cell proliferation and neointimal hyperplasia may still induce in-stent restenosis (ISR). Therefore, some drug eluting stents have been introduced to reduce ISR. In this study, heparin (Hep) combined with calcium phosphate (CaP) and gelatin (Gel) is co-deposited on NiTi alloy in order to promote the hemocompatibility of NiTi substrate and fabricate the sustained heparin releasing system. Polarization tests are carried out in several solutions to investigate deposition mechanisms. Heparin contained composite coatings are characterized by X-ray diffractometry (XRD), Field emission scanning electron microscope (FESEM), Fourier transform infrared spectroscopy (FTIR), toluidine blue colorimetric assay, UV-visible spectrometer and kinetic clotting tests. The consequences indicate that heparin accompanied with CaP, and Gel through ionic bonds can be loaded on the NiTi alloy, respectively. The porous post HA coating can enhance drug content from 147.06±68.66 μg/cm2 of single layer coating (CaP-Hep) to 191.58±11.87 μg/cm2 of bilayer coating (HA/CaP-Hep) and further to 324.87±4.94 μg/cm2 of trilayer coating (HA/CaP-Hep/Gel-Hep) by adding the third layer which also results in the in vitro heparin release prolonging from 1 day burst to more than 35 days sustaining. As the result of clotting tests, drug loaded composite coatings reveal good anticoagulant property which is proportional to the cumulative content of drug release in an hour, indicating no denaturalization of heparin found during the electrochemical process. Shiow-Kang Yen 顏秀崗 2012 學位論文 ; thesis 47 en_US |
collection |
NDLTD |
language |
en_US |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立中興大學 === 材料科學與工程學系所 === 100 === Although the initial success of bare metal stents (BMS) has significantly reduced the restenosis rate from 35% for Percutaneous transluminal coronary angioplasty (PTCA) to 25%, the biological mechanism such as smooth muscle cell proliferation and neointimal hyperplasia may still induce in-stent restenosis (ISR). Therefore, some drug eluting stents have been introduced to reduce ISR. In this study, heparin (Hep) combined with calcium phosphate (CaP) and gelatin (Gel) is co-deposited on NiTi alloy in order to promote the hemocompatibility of NiTi substrate and fabricate the sustained heparin releasing system. Polarization tests are carried out in several solutions to investigate deposition mechanisms. Heparin contained composite coatings are characterized by X-ray diffractometry (XRD), Field emission scanning electron microscope (FESEM), Fourier transform infrared spectroscopy (FTIR), toluidine blue colorimetric assay, UV-visible spectrometer and kinetic clotting tests. The consequences indicate that heparin accompanied with CaP, and Gel through ionic bonds can be loaded on the NiTi alloy, respectively. The porous post HA coating can enhance drug content from 147.06±68.66 μg/cm2 of single layer coating (CaP-Hep) to 191.58±11.87 μg/cm2 of bilayer coating (HA/CaP-Hep) and further to 324.87±4.94 μg/cm2 of trilayer coating (HA/CaP-Hep/Gel-Hep) by adding the third layer which also results in the in vitro heparin release prolonging from 1 day burst to more than 35 days sustaining. As the result of clotting tests, drug loaded composite coatings reveal good anticoagulant property which is proportional to the cumulative content of drug release in an hour, indicating no denaturalization of heparin found during the electrochemical process.
|
author2 |
Shiow-Kang Yen |
author_facet |
Shiow-Kang Yen Po-Yin Cheng 鄭博尹 |
author |
Po-Yin Cheng 鄭博尹 |
spellingShingle |
Po-Yin Cheng 鄭博尹 Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents |
author_sort |
Po-Yin Cheng |
title |
Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents |
title_short |
Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents |
title_full |
Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents |
title_fullStr |
Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents |
title_full_unstemmed |
Heparin Contained Multilayer Composite Coatings on NiTi Alloy for Cardiovascular Stents |
title_sort |
heparin contained multilayer composite coatings on niti alloy for cardiovascular stents |
publishDate |
2012 |
url |
http://ndltd.ncl.edu.tw/handle/01856005936605595944 |
work_keys_str_mv |
AT poyincheng heparincontainedmultilayercompositecoatingsonnitialloyforcardiovascularstents AT zhèngbóyǐn heparincontainedmultilayercompositecoatingsonnitialloyforcardiovascularstents AT poyincheng bèifùhángānsùduōcéngfùhécáiyúniètàihéjīnyīngyòngyúxīnzàngxuèguǎnzhījiàzhīyánjiū AT zhèngbóyǐn bèifùhángānsùduōcéngfùhécáiyúniètàihéjīnyīngyòngyúxīnzàngxuèguǎnzhījiàzhīyánjiū |
_version_ |
1718388533878587392 |